Resveratrol’s anti-tumor effects in A549 xenografts were reduced in Forkhead box protein C2 (FOXC2)-overexpressing A549 xenografts, which suggests that resveratrol possibly induces anti-tumor activity through FOXC2 [289]. This evidence concerns the gene FOXC2 and neoplasm.